Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,433.70
+7.30 (0.51%)
Jun 1, 2026, 3:29 PM IST
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 828.46 billion as of June 1, 2026. Its market cap has increased by 22.50% in one year.
Market Cap
828.46B
Enterprise Value
802.93B
Revenue
336.53B
Ranking
n/a
PE Ratio
23.64
Stock Price
1,433.70
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 828.46B, an increase of 8,526.80%. That is a compound annual growth rate of 20.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 828.46B | 20.57% |
| Dec 31, 2025 | 687.09B | -11.35% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.77T |
| Cipla | 1.13T |
| Zydus Lifesciences | 1.08T |
| Mankind Pharma | 980.71B |
| Laurus Labs | 735.28B |
| Alkem Laboratories | 657.37B |
| Glenmark Pharmaceuticals | 641.98B |
| Ipca Laboratories | 386.75B |